Labcorp officer Caveney proposes $744K share sale

The shares listed for sale were acquired from the issuer through restricted stock vesting between November 5, 2021, and February 11, 2025.

Available on EDGAR 11/10/2026 - 04:05 PM EST Accepted by SEC EDGAR 11/10/2026 - 04:04 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Labcorp Holdings Inc. officer Brian J. Caveney reported a proposed sale of 2,000 common shares, with an approximate sale date of November 10, 2026, and an aggregate market value of $744,080.20. The securities listed for sale were acquired from the issuer through restricted stock vesting; Fidelity Brokerage Services LLC is listed as broker.

Key Figures

Proposed sale: 2,000 common shares Aggregate market value: $744,080.20 Shares outstanding: 81,200,000 shares +5 more

8 metrics

Proposed sale 2,000 common shares Approximate sale date: November 10, 2026

Aggregate market value $744,080.20 For the common shares listed for sale

Shares outstanding 81,200,000 shares Number stated in the securities information

Restricted stock vesting 680 shares Acquired November 5, 2021

Restricted stock vesting 296 shares Acquired February 2, 2022

Restricted stock vesting 395 shares Acquired February 4, 2022

Restricted stock vesting 358 shares Acquired March 27, 2022

Restricted stock vesting 271 shares Acquired February 11, 2025

Key Terms

Aggregate Market Value, Restricted Stock Vesting, attorney-in-fact

3 terms

Aggregate Market Value financial

"Aggregate Market Value"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

Restricted Stock Vesting financial

"Nature of Acquisition Transaction: Restricted Stock Vesting"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

attorney-in-fact technical

"as attorney-in-fact for Brian J. Caveney"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many LH shares did officer Brian J. Caveney plan to sell?

Brian J. Caveney, an officer of Labcorp Holdings Inc. (LH), listed 2,000 common shares for a proposed sale, with an approximate sale date of November 10, 2026.

What is the reported market value of Brian J. Caveney's planned LH sale?

The notice lists an aggregate market value of $744,080.20 for the 2,000 common shares listed for sale.

How did Brian J. Caveney acquire the LH shares listed for sale?

The shares listed for sale were acquired from the issuer through restricted stock vesting: 680 shares on November 5, 2021; 296 shares on February 2, 2022; 395 shares on February 4, 2022; 358 shares on March 27, 2022; and 271 shares on February 11, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001717915
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	LABCORP HOLDINGS INC.
SEC File Number	001-11353
Address of Issuer	358 S MAIN ST BURLINGTON NORTH CAROLINA 27215
Phone	3362291127
Name of Person for Whose Account the Securities are To Be Sold	Caveney Brian J
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2000	744080.20	81200000	11/10/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/05/2021	Restricted Stock Vesting	Issuer			680	11/05/2021	Compensation
Common	02/02/2022	Restricted Stock Vesting	Issuer			296	02/02/2022	Compensation
Common	02/04/2022	Restricted Stock Vesting	Issuer			395	02/04/2022	Compensation
Common	03/27/2022	Restricted Stock Vesting	Issuer			358	03/27/2022	Compensation
Common	02/11/2025	Restricted Stock Vesting	Issuer			271	02/11/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	11/10/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jared Cook, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Brian J. Caveney
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)